Literature DB >> 26884832

MiR-30a-5p suppresses cell growth and enhances apoptosis of hepatocellular carcinoma cells via targeting AEG-1.

Rongquan He1, Lihua Yang1, Xiaomiao Lin2, Xin Chen3, Xinggu Lin4, Fanglin Wei3, Xiaona Liang3, Yihuan Luo3, Yuzhuang Wu3, Tingqing Gan1, Yiwu Dang3, Gang Chen3.   

Abstract

BACKGROUND: MiR-30a-5p has been reported to play vital roles in the carcinogenesis and progression of various malignancies via different molecular mechanisms. However, the role and target genes of miR-30a-5p in hepatocellular carcinoma (HCC) remain still unclear. In silico analysis finds that there are complementary sequences between the 3'-untrasnlated region of astrocyte elevated gene 1 (AEG-1) and miR-30a-5p. Herein, we investigated the biological function of miR-30a-5p, as well as the potential molecular mechanism via targeting AEG-1 in HCC cells.
MATERIALS AND METHODS: MiR-30a-5p inhibitor, miR-30a-5p mimic, AEG-1 siRNAs, as well as their negative controls were transfected into HCC cell lines HepG2, SMMC-7221, HepB3 and SNU449. Then, the in vitro influence and mechanism of miR-30a-5p on cell viability, proliferation, caspase-3/7 activity and apoptosis were studied, as assessed by different methods, including spectrophotometry, fluorimetry, fluorescence microscopy of Hoechst 33342/propidium iodide double chromatin staining, western blot and dual luciferase reporter assay, respectively.
RESULTS: MiR-30a-5p mimic markedly inhibited cell growth, also induced caspase-3/7 activity and apoptosis in all four HCC cell lines tested. The strongest effect was observed in HepG2 and SMMC-7721 cells. However, this effect was slightly weaker than that of AEG-1 siRNAs. Transfection of miR-30a-5p mimic led to a markedly reduced AEG-1 protein level and further dual luciferase reporter assay confirmed that AEG-1 was one of the target genes of miR-30a-5p in HCC cells.
CONCLUSIONS: MiR-30a-5p may play an essential role in the cell growth and apoptosis of HCC cells, partially via targeting AEG-1.

Entities:  

Keywords:  AEG-1; apoptosis; caspase; cell growth; hepatocellular carcinoma; miR-30a-5p

Mesh:

Substances:

Year:  2015        PMID: 26884832      PMCID: PMC4730045     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  46 in total

1.  MicroRNA-30a inhibits epithelial-to-mesenchymal transition by targeting Snai1 and is downregulated in non-small cell lung cancer.

Authors:  Regalla Kumarswamy; Giridhar Mudduluru; Paolo Ceppi; Santoshi Muppala; Miroslaw Kozlowski; Jacek Niklinski; Mauro Papotti; Heike Allgayer
Journal:  Int J Cancer       Date:  2011-08-08       Impact factor: 7.396

Review 2.  Clinicopathological and prognostic significance of high Ki-67 labeling index in hepatocellular carcinoma patients: a meta-analysis.

Authors:  Yihuan Luo; Fanghui Ren; Yongru Liu; Zhenhong Shi; Zhong Tan; Huojie Xiong; Yiwu Dang; Gang Chen
Journal:  Int J Clin Exp Med       Date:  2015-07-15

Review 3.  Treatment algorithms for managing hepatocellular carcinoma.

Authors:  Vivek A Saraswat; Gaurav Pandey; Sachin Shetty
Journal:  J Clin Exp Hepatol       Date:  2014-06-06

Review 4.  MiRNA molecular profiles in human medical conditions: connecting lung cancer and lung development phenomena.

Authors:  Mohamad-Reza Aghanoori; Behnaz Mirzaei; Mahmood Tavallaei
Journal:  Asian Pac J Cancer Prev       Date:  2014

5.  Quantification of epidermal growth factor receptor T790M mutant transcripts in lung cancer cells by real-time reverse transcriptase-quantitative polymerase chain reaction.

Authors:  Gang Chen; Peter Kronenberger; Ijeoma Adaku Umelo; Erik Teugels; Jacques De Grève
Journal:  Anal Biochem       Date:  2009-12-02       Impact factor: 3.365

Review 6.  Molecular mechanism of hepatitis B virus-induced hepatocarcinogenesis.

Authors:  Mirko Tarocchi; Simone Polvani; Giada Marroncini; Andrea Galli
Journal:  World J Gastroenterol       Date:  2014-09-07       Impact factor: 5.742

7.  Targeting the epidermal growth factor receptor in non-small cell lung cancer cells: the effect of combining RNA interference with tyrosine kinase inhibitors or cetuximab.

Authors:  Gang Chen; Peter Kronenberger; Erik Teugels; Ijeoma Adaku Umelo; Jacques De Grève
Journal:  BMC Med       Date:  2012-03-21       Impact factor: 8.775

8.  MicroRNA miR-30 family regulates non-attachment growth of breast cancer cells.

Authors:  Maria Ouzounova; Tri Vuong; Pierre-Benoit Ancey; Mylène Ferrand; Geoffroy Durand; Florence Le-Calvez Kelm; Carlo Croce; Chantal Matar; Zdenko Herceg; Hector Hernandez-Vargas
Journal:  BMC Genomics       Date:  2013-02-28       Impact factor: 3.969

9.  Underexpression of miR-34a in hepatocellular carcinoma and its contribution towards enhancement of proliferating inhibitory effects of agents targeting c-MET.

Authors:  Yiwu Dang; Dianzhong Luo; Minhua Rong; Gang Chen
Journal:  PLoS One       Date:  2013-04-10       Impact factor: 3.240

10.  Synergistic effect of afatinib with su11274 in non-small cell lung cancer cells resistant to gefitinib or erlotinib.

Authors:  Gang Chen; Alfiah Noor; Peter Kronenberger; Erik Teugels; Ijeoma Adaku Umelo; Jacques De Grève
Journal:  PLoS One       Date:  2013-03-18       Impact factor: 3.240

View more
  29 in total

1.  Depletion of astrocyte elevated gene-1 suppresses tumorigenesis through inhibition of Akt activity in bladder cancer cells.

Authors:  Lianhua Zhang; Guoliang Yang; Haige Chen; Yiran Huang; Wei Xue; Juanjie Bo
Journal:  Am J Transl Res       Date:  2017-12-15       Impact factor: 4.060

2.  MicroRNA-101-3p suppresses proliferation and migration in hepatocellular carcinoma by targeting the HGF/c-Met pathway.

Authors:  Yang Liu; Juan Tan; Shuangyan Ou; Jun Chen; Limin Chen
Journal:  Invest New Drugs       Date:  2019-03-30       Impact factor: 3.850

3.  * Glioblastoma Exosomes for Therapeutic Angiogenesis in Peripheral Ischemia.

Authors:  Anthony Monteforte; Brian Lam; Michael B Sherman; Kayla Henderson; Andrew D Sligar; Adrianne Spencer; Brian Tang; Andrew K Dunn; Aaron B Baker
Journal:  Tissue Eng Part A       Date:  2017-11       Impact factor: 3.845

4.  Long noncoding RNA NORAD regulates lung cancer cell proliferation, apoptosis, migration, and invasion by the miR-30a-5p/ADAM19 axis.

Authors:  Jun Li; Xia Xu; Cungang Wei; Lei Liu; Tengqi Wang
Journal:  Int J Clin Exp Pathol       Date:  2020-01-01

5.  The essential role of MTDH in the progression of HCC: a study with immunohistochemistry, TCGA, meta-analysis and in vitro investigation.

Authors:  Rongquan He; Li Gao; Jie Ma; Zhigang Peng; Shengsheng Zhou; Lihua Yang; Zhenbo Feng; Yiwu Dang; Gang Chen
Journal:  Am J Transl Res       Date:  2017-04-15       Impact factor: 4.060

6.  Metadherin facilitates podocyte apoptosis in diabetic nephropathy.

Authors:  Wen-Ting Liu; Fen-Fen Peng; Hong-Yu Li; Xiao-Wen Chen; Wang-Qiu Gong; Wen-Jing Chen; Yi-Hua Chen; Pei-Lin Li; Shu-Ting Li; Zhao-Zhong Xu; Hai-Bo Long
Journal:  Cell Death Dis       Date:  2016-11-24       Impact factor: 8.469

7.  miR-155-5p modulates malignant behaviors of hepatocellular carcinoma by directly targeting CTHRC1 and indirectly regulating GSK-3β-involved Wnt/β-catenin signaling.

Authors:  Gang Chen; Dongdong Wang; Xiongqi Zhao; Jun Cao; Yingpeng Zhao; Fan Wang; Jianhua Bai; Ding Luo; Li Li
Journal:  Cancer Cell Int       Date:  2017-12-08       Impact factor: 5.722

8.  Potential role of microRNA‑223‑3p in the tumorigenesis of hepatocellular carcinoma: A comprehensive study based on data mining and bioinformatics.

Authors:  Rui Zhang; Li-Jie Zhang; Mei-Ling Yang; Lan-Shan Huang; Gang Chen; Zhen-Bo Feng
Journal:  Mol Med Rep       Date:  2017-11-27       Impact factor: 2.952

9.  MicroRNA-30a functions as tumor suppressor and inhibits the proliferation and invasion of prostate cancer cells by down-regulation of SIX1.

Authors:  Qinghuan Zhu; Hongzhi Li; Yingjie Li; Lining Jiang
Journal:  Hum Cell       Date:  2017-06-01       Impact factor: 4.174

10.  Clinicopathological role of miR-30a-5p in hepatocellular carcinoma tissues and prediction of its function with bioinformatics analysis.

Authors:  Wen-Ting Huang; Zu-Xuan Chen; Rong-Quan He; Yu-Zhuang Wu; Shu-Ya Yin; Xiao-Na Liang; Gang Chen; Hong Yang; Zhi-Gang Peng; Li-Hua Yang
Journal:  Onco Targets Ther       Date:  2016-08-12       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.